Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
267
datasets available to search
ShareScore release 0.9.0
Dataset results
267 results for “Olanzapine”
Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania
ClinicalTrials.gov study NCT00190892. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia
ClinicalTrials.gov study NCT00051298. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective Disorder
ClinicalTrials.gov study NCT06319170. IPD Sharing: YES. Countries: 1. Publications: 0.
Exercise and Olanzapine-samidorphan
ClinicalTrials.gov study NCT06740890. IPD Sharing: YES. Countries: 1. Publications: 2.
6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptom Patients Who Completed the Protocol 25543 (25544)(P05777)
ClinicalTrials.gov study NCT00265343. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular Cancer
ClinicalTrials.gov study NCT05244577. IPD Sharing: NO. Countries: 1. Publications: 9.
Figure 3 from: Ali ZJM, Al-juhiashi AMR (2024) Role of D2 receptor (–141 C Ins/Del) genetic polymorphism on olanzapine-induced adverse drug reaction in schizophrenic patients. Pharmacia 71: 1-8. https://doi.org/10.3897/pharmacia.71.e112064
Figure 3 The Prevalence of D2 receptor alleles rs1799732 (141c ins/del) among both male and female volunteers.
Figure 3 from: Al-Musawi ZJMA, Al-Juhaishi AMR (2024) Association study between D2 receptor A-241G, rs1799978 genetic variation and olanzapine efficacy in Iraqi schizophrenic patients. Pharmacia 71: 1-6. https://doi.org/10.3897/pharmacia.71.e111984
Figure 3 The Prevalence of D2 receptor alleles A-241G (rs1799978) among both male and female volunteers.
Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (25543)(COMPLETED)(P05817)
ClinicalTrials.gov study NCT00212836. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Metabolic Effects of Olanzapine in Healthy Males
ClinicalTrials.gov study NCT01496183. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Asenapine With Placebo and Olanzapine (41021)(P05933)
ClinicalTrials.gov study NCT00156117. IPD Sharing: Not stated. Countries: 0. Publications: 2.
A Research Study Examining the Use of Olanzapine for the Prevention of Migraine
ClinicalTrials.gov study NCT00203307. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Pilot Study on the Efficacy and Safety of Olanzapine in Gastroparesis
ClinicalTrials.gov study NCT01625923. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Olanzapine in Patients With Acute Agitation
ClinicalTrials.gov study NCT05803642. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Trial Evaluating Three Fixed Doses of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia
ClinicalTrials.gov study NCT00083668. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Utility of Olanzapine in the Treatment of Opioid Withdrawal in the ED
ClinicalTrials.gov study NCT02643355. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacokinetic Characterization of Intramuscular Olanzapine Depot
ClinicalTrials.gov study NCT00094640. IPD Sharing: Not stated. Countries: 8. Publications: 3.
Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With Olanzapine
ClinicalTrials.gov study NCT00259272. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine in Adult Subjects With Moderate to Severe Negative Symptoms of
ClinicalTrials.gov study NCT06107803. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PET Imaging and Olanzapine Treatment in Borderline Personality Disorder
ClinicalTrials.gov study NCT00275301. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.